Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 159

Despegar draws up $100m IPO plans

Latin American travel booking platform Despegar has filed to go public in the US, two years after Expedia invested $270m for a 16% share in the company.

Aug 17, 2017

Youon docks at $87m IPO

Youon has become the first bike sharing company to complete an initial public offering in China, providing an exit to Alibaba's Ant Financial affiliate.

Aug 17, 2017

MongoDB makes confidential IPO move

The Salesforce, Intel and Red Hat-backed database software provider, valued at $1.6bn as of 2016, has reportedly filed for an initial public offering.

Aug 16, 2017

Wantedly wanders toward public markets

The CyberAgent and Nihon Keizai Shimbun-backed recruitment and networking platform developer is set to float in its home country of Japan next month.

Aug 14, 2017

Iheima hits public markets

Iheima has raised $27.3m in its initial public offering, becoming the first incubator to float in China and providing an exit to corporate investors Toread and Youyou.

Aug 10, 2017

Clementia cleaves $120m from IPO

UCB Pharma scored an exit after the bone disease therapy developer floated at the top of its range, having secured $92.5m in funding over the past two years.

Aug 3, 2017

Roku to greenlight IPO

Roku, which first considered a flotation almost three years ago, is said to have hired underwriters for an initial public offering that could value it at up to $1bn.

Jul 14, 2017

Sienna to scratch IPO itch

Topical skin treatment developer and JLabs graduate Sienna Biopharmaceuticals has filed for a $74.8m initial public offering, after raising $86m in venture funding.

Jul 7, 2017

MyRepublic begins journey to IPO

Sinar Mas and Dian Swastatika Sentosa-backed internet service provider MyRepublic is targeting the end of 2018 for an initial public offering, its CEO has said.

Jul 6, 2017

Clementia to form $115m IPO

The bone disease therapy developer had raised $92.5m from investors including UCB Pharma across two rounds in 2015.

Jul 4, 2017
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here